Persistent URL of this record https://hdl.handle.net/1887/95820
In Collections
This item can be found in the following collections:
![NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION
- All authors
- Klein, M.; Reijneveld, J.C.; Idbaih, A.; Brandes, A.; Taal, W.; Clement, P.M.; Domont, J.; Campone, M.; Taphoorn, M.J.B.; Stupp, R.; Fabbro, M.; Rhun, E. le; Dubois, F.; Weller, M.; Golfinopoulos, V.; Platten, M.; Gorlia, T.; Bent, M. van den; Wick, W.
- Date
- 2017-11-30
- Journal
- Neuro-Oncology
- Volume
- 19
- Pages
- 142 - 142